The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
Open accessAbstract
In order to investigate the general cause of beta-adrenergic receptor neuroeffector abnormalities in the failing human heart, we measured ventricular myocardial adrenergic receptors, adrenergic neurotransmitters, and beta-adrenergic receptor-effector responses in nonfailing and failing hearts taken from nonfailing organ donors, subjects with endstage biventricular failure due to idiopathic dilated cardiomyopathy (IDC), and subjects with primary pulmonary hypertension (PPH) who exhibited isolated right ventricular failure. Relative to nonfailing PPH left ventricles, failing PPH right ventricles exhibited (a) markedly decreased beta 1-adrenergic receptor density, (b) marked depletion of tissue norepinephrine and neuropeptide Y, (c) decreased adenylate cyclase stimulation in response to the beta agonists isoproterenol and zinterol, and (d) decreased adenylate cyclase stimulation in response to Gpp(NH)p and forskolin. These abnormalities were directionally similar to, but generally more pronounced than, corresponding findings in failing IDC right ventricles, whereas values for these parameters in nonfailing left ventricles of PPH subjects were similar to values in the nonfailing left ventricles of organ donors. Additionally, relative to paired nonfailing PPH left ventricles and nonfailing right ventricles from organ donors, failing right ventricles from PPH subjects exhibited decreased adenylate cyclase stimulation by MnCl2. These data indicate that: (a) Adrenergic neuroeffector abnormalities present in the failing human heart are due to local mechanisms; systemic processes do not produce beta-adrenergic neuroeffector abnormalities. (b) Pressure-overloaded failing right ventricles of PPH subjects exhibit decreased activity of the catalytic subunit of adenylate cyclase, an abnormality not previously described in the failing human heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simplification of the protein assay method of Lowry et al. which is more generally applicable
Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,524
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
A highly sensitive adenylate cyclase assay
Salomon, Y., Londos, C., & Rodbell, M. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90222-x · Cited by 4,169
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Self-citationDifferentiation of Receptor Systems activated by Sympathomimetic Amines
LANDS, A. M., ARNOLD, A., MCAULIFF, J. P., LUDUENA, F. P., & BROWN, T. G. (1967) · Nature · doi:10.1038/214597a0 · Cited by 2,065
Bristow, M. R., Ginsburg, R., Umans, V, Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., & Jamieson, S. (1986) · Circulation Research · doi:10.1161/01.res.59.3.297 · Cited by 1,327
Self-citationHasking, G. J., Esler, M. D., Jennings, G. L., Burton, D., Johns, J. A., & Korner, P. I. (1986) · Circulation · doi:10.1161/01.cir.73.4.615 · Cited by 1,028
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure
Chidsey, C. A., Braunwald, E., & Morrow, A. G. (1965) · The American Journal of Medicine · doi:10.1016/0002-9343(65)90211-1 · Cited by 568
Fowler, M. B., Laser, J. A., Hopkins, G. L., Minobe, W., & Bristow, M. R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1290 · Cited by 562
Self-citationIncrease of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart.
Feldman, A. M., Cates, A. E., Veazey, W. B., Hershberger, R. E., Bristow, M. R., Baughman, K. L., Baumgartner, W. A., & Van Dop, C. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113569 · Cited by 543
Self-citationNeurohormonal interactions and adaptations in congestive heart failure.
Packer, M. (1988) · Circulation · doi:10.1161/01.cir.77.4.721 · Cited by 541
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.
Dzau, V. J., Colucci, W. S., Hollenberg, N. K., & Williams, G. H. (1981) · Circulation · doi:10.1161/01.cir.63.3.645 · Cited by 534
Dzau, V. J., Packer, M., Lilly, L. S., Swartz, S. L., Hollenberg, N. K., & Williams, G. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100603 · Cited by 428
Bristow, M. R., Hershberger, R. E., Port, J. D., Minobe, W., & Rasmussen, R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11117-6 · Cited by 381
Self-citationBristow, M. R., Anderson, F. L., Port, J. D., Skerl, L., Hershberger, R. E., Larrabee, P., O'Connell, J. B., Renlund, D. G., Volkman, K., & Murray, J. (1991) · Circulation · doi:10.1161/01.cir.84.3.1024 · Cited by 252
Self-citationCatecholamines predict outcome in traumatic brain injury
Hamill, R. W., Woolf, P. D., McDonald, J. V., Lee, L. A., & Kelly, M. (1987) · Annals of Neurology · doi:10.1002/ana.410210504 · Cited by 216
Swedberg, K., Viquerat, C., Rouleau, J.-L., Roizen, M., Atherton, B., Parmley, W. W., & Chatterjee, K. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80208-8 · Cited by 182
Alpha-1 adrenergic receptors in the nonfailing and failing human heart.
Bristow, M. R., Minobe, W., Rasmussen, R., Hershberger, R. E., & Hoffman, B. B. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13255-2 · Cited by 175
Self-citationUptake Processes for Biogenic Amines
Iversen, L. L. (1975) · Biochemistry of Biogenic Amines · doi:10.1007/978-1-4684-3171-1_7 · Cited by 174
Neurohumoral control mechanisms in congestive heart failure
Cohn, J. N., Levine, T. B., Francis, G. S., & Goldsmith, S. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90739-0 · Cited by 166
Brodde, O., Zerkowski, H., Doetsch, N., Motomura, S., Khamssi, M., & Michel, M. C. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90181-2 · Cited by 145
Liang, C., Fan, T.-H., Sullebarger, J. T., & Sakamoto, S. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114294 · Cited by 143
Pharmacology and inotropic potential of forskolin in the human heart.
Bristow, M. R., Ginsburg, R., Strosberg, A. D., Montgomery, W., & Minobe, W. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111404 · Cited by 135
Self-citationProperties of the separated catalytic and regulatory units of brain adenylate cyclase.
Strittmatter, S. M., & Neer, E. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6344 · Cited by 109
Port, J. D., Gilbert, E. M., Larrabee, P. S., Mealey, P. C., Volkman, K., Ginsburg, R., Hershberger, R. E., Murray, J., & Bristow, M. R. (1990) · Circulation · doi:10.1161/01.cir.81.3.929 · Cited by 100
Self-citationChronic norepinephrine elicits desensitization by uncoupling the beta-receptor.
Vatner, D. E., Vatner, S. F., Nejima, J., Uemura, N., Susanni, E. E., Hintze, T. H., & Homcy, C. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114357 · Cited by 85
Uptake of catecholamines by human cardiac muscle in vitro.
Petch, M. C., & Nayler, W. G. (1979) · Heart · doi:10.1136/hrt.41.3.336 · Cited by 71
Sole, M. J., Helke, C. J., & Jacobowitz, D. M. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90246-6 · Cited by 62
Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure
Pierpont, G. L., Francis, G. S., DeMaster, E. G., OLIVARI, M. T., Ring, W. S., Goldenberg, I. F., Reynolds, S., & Cohn, J. N. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90234-7 · Cited by 49
Cited by
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)
Marx, S. O., Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., & Marks, A. R. (2000) · Cell · doi:10.1016/s0092-8674(00)80847-8 · Cited by 1,978
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
Self-citation
Metadata
- Authors
- Bristow, M. R., Minobe, W., Rasmussen, R., Larrabee, P., Skerl, L., Klein, J. W., Anderson, F. L., Murray, J., Mestroni, L., & Karwande, S. V.
- Venue
- Journal of Clinical Investigation
- Published
- 1992-03-01
- Volume
- 89
- Issue
- 3
- Pages
- 803-815
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2162394869
- Cited by
- 318
- References
- 31
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.